BUILDING A BUSINESS

How large pharma impacts biotechnology startup success

Nature Biotechnology (2021)Cite this article

Subjects

Implications for bioentrepreneurs.

Access options

Fig. 1: Involvement of large pharma throughout the startup life cycle.
Fig. 2: Success rate for startups with and without large pharma investors.
Fig. 3: Median current market capitalization and acquisition value for startups with and without large pharma investors.
Fig. 4: Startup success rate by development stage at first venture financing round.
Fig. 5: Investor ties to large pharma. Investors’ share of their successful portfolio companies that have exited via acquisition and share of investors’ portfolio companies that have attracted large pharma in the same or subsequent years of the investment.

References

  1. 1.

    Geilinger, U. & Bujak, E. 2019 HBM New Drug Approval Report. https://www.hbmpartners.com/en/news-research/?pageIdd55d7643=4#tab_d858312ec47cb6a64ac33daec0044371_3 (2019).

  2. 2.

    Schuhmacher, A., Gassmann, O. & Hinder, M. J. Transl. Med. 14, 105–116 (2016).

    Article  Google Scholar 

  3. 3.

    Senior, M. Nat. Biotechnol. 36, 291–292 (2018).

    CAS  Article  Google Scholar 

  4. 4.

    Chin, M. H. W., Gentleman, E., Coppens, M.-O. & Day, E. M. Trends Biotechnol. 38, 1054–1065 (2020).

    Article  Google Scholar 

  5. 5.

    Christel, M. Pharmaceutical Executive 39 (6), 12–23 (2019).

    Google Scholar 

  6. 6.

    Rooswinkel, R. W., Berbers, D. S. W., Claassen, E. H. J. H. M. & van Deventer, S. Nat. Biotechnol. 34, 1095–1098 (2016).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. BioGeneration Ventures (BGV), Naarden, the Netherlands

    Gina Melchner von Dydiowa & Daniela S. Couto

  2. Forbion Capital Partners, Naarden, the Netherlands

    Sander van Deventer

Authors
  1. Gina Melchner von Dydiowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sander van Deventer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela S. Couto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniela S. Couto.

Ethics declarations

Competing interests

G.M.v.D. and D.S.C. are employed by BioGeneration Ventures and S.v.D. is employed by Forbion Capital Partners. These companies invest in biotech ventures.

Supplementary information

Supplementary Information

Supplementary Table 1

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Melchner von Dydiowa, G., van Deventer, S. & Couto, D.S. How large pharma impacts biotechnology startup success. Nat Biotechnol (2021). https://doi.org/10.1038/s41587-021-00821-x

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing